Zuellig pledges to invest over S$50m in S'pore centre
Singapore
ZUELLIG Pharma plans to work with Singapore's National Healthcare Group to develop predictive models for early health screening, and carry out treatment cost versus quality analysis, using data analytics. It announced this on Wednesday, following an investment commitment of more than S$50 million over the next five years in its new Singapore-based innovation centre.
The centre, known as Zuellig Health Solutions (ZHS), will develop data, digital and disease management solutions. These are meant to help doctors develop more effective treatment plans, support patients managing chronic conditions, and help payors manage healthcare costs, it said.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Indian central bank issues draft guidelines for web aggregators of loan products
Vietnam National Assembly head resigns amid graft purge
China central bank flags bond investment risks to some financial institutions: sources
Xi tells Blinken US, China should be 'partners, not rivals'
Indonesia’s push for regional economic integration to continue under Prabowo: Vivian Balakrishnan
Outgoing Singapore, Indonesia leaders to hold their final retreat in Bogor on Apr 29